Celsion Corp (CLSN.OQ)
CLSN.OQ on NASDAQ Stock Exchange Capital Market
1.23USD
1:00pm EDT
1.23USD
1:00pm EDT
Price Change (% chg)
$0.02 (+1.65%)
$0.02 (+1.65%)
Prev Close
$1.21
$1.21
Open
$1.24
$1.24
Day's High
$1.24
$1.24
Day's Low
$1.22
$1.22
Volume
24,300
24,300
Avg. Vol
627,681
627,681
52-wk High
$9.43
$9.43
52-wk Low
$0.75
$0.75
About
Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical... (more)
Overall
| Beta: | 1.48 |
| Market Cap (Mil.): | $69.09 |
| Shares Outstanding (Mil.): | 57.10 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CLSN.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.70 | -- | -- |
| ROI: | -69.04 | -2.58 | 18.76 |
| ROE: | -97.35 | -2.66 | 19.59 |
BRIEF-Celsion up in premarket trading after comments
NEW YORK, April 23 - Celsion Corp : * Up 17 percent in premarket trading after comments
Competitors
| Price | Change | |
|---|---|---|
| Warner Chilcott Plc (WCRX.OQ) | $21.59 | +0.28 |
| Valeant Pharmaceuticals Intl Inc (VRX.TO) | $98.95 | +3.65 |
| Actelion Ltd (ATLN.VX) | CHF61.50 | +0.50 |
| Alexion Pharmaceuticals, Inc. (ALXN.OQ) | $117.69 | +1.46 |
| Advanced Medical Solutions Group plc (AMSU.L) | 77.00p | +0.25 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$460.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

